GENFLOW BIOSCIENCES PLC — Investor Relations & Filings
Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Group of companies' accounts made up to 2025-12-31 | 2026-05-15 | English | |
| Annual financial statements 2025 | 2026-05-13 | English | |
| Annual financial statements 2025 | 2026-05-13 | English | |
| Exercise of Warrants and Issue of Equity | 2026-05-08 | English | |
| Annual Report 2025 | 2026-04-30 | English | |
| Final Results | 2026-04-30 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46834865 | Group of companies' accounts made up to 2025-12-31 | 2026-05-15 | English | ||
| 45660039 | Annual financial statements 2025 | 2026-05-13 | English | ||
| 45660034 | Annual financial statements 2025 | 2026-05-13 | English | ||
| 44177338 | Exercise of Warrants and Issue of Equity | 2026-05-08 | English | ||
| 39133438 | Annual Report 2025 | 2026-04-30 | English | ||
| 39084660 | Final Results | 2026-04-30 | English | ||
| 37867403 | Expansion of Confidentiality Agreements | 2026-04-28 | English | ||
| 34688977 | Strategic Technology Collaboration | 2026-04-20 | English | ||
| 34392433 | International Patent Publication | 2026-04-13 | English | ||
| 33889131 | Update on the Dog Study | 2026-04-08 | English | ||
| 33101656 | Total Voting Rights | 2026-03-31 | English | ||
| 34566868 | Resolutions from GM | 2026-03-10 | English | ||
| 34566621 | Issue of Equity & PDMR Notifications | 2026-03-05 | English | ||
| 32863359 | Result of GM | 2026-03-02 | English | ||
| 32859832 | Receipt of First Tranche of Grant | 2026-03-02 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GENFLOW BIOSCIENCES PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
GENFLOW BIOSCIENCES PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5094/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5094 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5094 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5094 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5094}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENFLOW BIOSCIENCES PLC (id: 5094)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.